[go: up one dir, main page]

PT93991A - Processo para a preparacao de solucoes estaveis de analogos de rebecamicina - Google Patents

Processo para a preparacao de solucoes estaveis de analogos de rebecamicina

Info

Publication number
PT93991A
PT93991A PT93991A PT9399190A PT93991A PT 93991 A PT93991 A PT 93991A PT 93991 A PT93991 A PT 93991A PT 9399190 A PT9399190 A PT 9399190A PT 93991 A PT93991 A PT 93991A
Authority
PT
Portugal
Prior art keywords
rebeccamycin
acid
stable solutions
rebecamycinal
analogs
Prior art date
Application number
PT93991A
Other languages
English (en)
Other versions
PT93991B (pt
Inventor
Ubrani V Venkataram
Miriam K Franchini
Joseph B Bogardus
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PT93991A publication Critical patent/PT93991A/pt
Publication of PT93991B publication Critical patent/PT93991B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
PT93991A 1989-05-10 1990-05-09 Processo para a preparacao de solucoes estaveis de analogos de rebecamicina PT93991B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/349,608 US5496809A (en) 1989-05-10 1989-05-10 Stable solutions of rebeccamycin analog

Publications (2)

Publication Number Publication Date
PT93991A true PT93991A (pt) 1991-02-08
PT93991B PT93991B (pt) 1996-11-29

Family

ID=23373191

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93991A PT93991B (pt) 1989-05-10 1990-05-09 Processo para a preparacao de solucoes estaveis de analogos de rebecamicina

Country Status (25)

Country Link
US (1) US5496809A (pt)
EP (1) EP0397147B1 (pt)
JP (1) JPH0643437B2 (pt)
KR (1) KR920004098B1 (pt)
CN (1) CN1054510C (pt)
AT (1) ATE117313T1 (pt)
AU (1) AU618896B2 (pt)
CA (1) CA2015632C (pt)
CZ (1) CZ283416B6 (pt)
DE (1) DE69016087T2 (pt)
DK (1) DK0397147T3 (pt)
EG (1) EG19218A (pt)
ES (1) ES2066902T3 (pt)
FI (1) FI95777C (pt)
GR (1) GR3015714T3 (pt)
HK (1) HK1005033A1 (pt)
HU (1) HU206627B (pt)
IE (1) IE66515B1 (pt)
IL (1) IL94312A (pt)
NO (1) NO176390C (pt)
PT (1) PT93991B (pt)
RU (1) RU2053766C1 (pt)
TW (1) TW202390B (pt)
YU (1) YU90490A (pt)
ZA (1) ZA903535B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69323183T2 (de) * 1992-03-20 1999-05-27 The Wellcome Foundation Ltd., Greenford Weitere indolderivate mit antiviraler wirkung
US5968961A (en) * 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
WO1998019707A1 (en) * 1996-11-05 1998-05-14 Alcon Laboratories, Inc. Polyhydroxy monocarboxylic and dicarboxylic acids and their lactones in ophthalmic compositions
US20040048012A1 (en) * 1996-11-18 2004-03-11 Weder Donald E. Polymeric materials having a matte finish on a surface thereof
CA2241609C (en) * 1997-06-26 2009-08-25 Southpac Trust International, Inc. Polymeric material having a cloth-like appearance
CN100344285C (zh) * 2005-02-03 2007-10-24 宋艳 多潘立酮水溶性制剂及其制备方法
JP4822151B2 (ja) * 2005-02-14 2011-11-24 山本光学株式会社 眼鏡保持バンドおよびその保持バンド付き眼鏡

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
US4808613A (en) * 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition

Also Published As

Publication number Publication date
CA2015632C (en) 1998-01-27
CZ283416B6 (cs) 1998-04-15
CN1054510C (zh) 2000-07-19
GR3015714T3 (en) 1995-07-31
CZ225590A3 (en) 1997-12-17
DK0397147T3 (da) 1995-03-20
JPH0317094A (ja) 1991-01-25
NO176390B (no) 1994-12-19
IL94312A0 (en) 1991-03-10
EP0397147A2 (en) 1990-11-14
PT93991B (pt) 1996-11-29
FI95777C (fi) 1996-03-25
ZA903535B (en) 1991-01-30
IE901687L (en) 1990-11-10
NO902048D0 (no) 1990-05-09
NO176390C (no) 1995-03-29
RU2053766C1 (ru) 1996-02-10
EP0397147A3 (en) 1991-06-12
JPH0643437B2 (ja) 1994-06-08
EP0397147B1 (en) 1995-01-18
AU618896B2 (en) 1992-01-09
DE69016087D1 (de) 1995-03-02
IE66515B1 (en) 1996-01-10
HU206627B (en) 1992-12-28
FI95777B (fi) 1995-12-15
US5496809A (en) 1996-03-05
AU5482390A (en) 1990-11-15
DE69016087T2 (de) 1995-05-24
ATE117313T1 (de) 1995-02-15
HU902989D0 (en) 1990-09-28
HUT54053A (en) 1991-01-28
CA2015632A1 (en) 1990-11-10
KR920004098B1 (ko) 1992-05-25
IL94312A (en) 1994-02-27
HK1005033A1 (en) 1998-12-18
TW202390B (pt) 1993-03-21
CN1047204A (zh) 1990-11-28
NO902048L (no) 1990-11-12
ES2066902T3 (es) 1995-03-16
KR900017596A (ko) 1990-12-19
YU90490A (en) 1991-10-31
FI902276A0 (fi) 1990-05-07
EG19218A (en) 1994-10-30

Similar Documents

Publication Publication Date Title
IS1553B (is) Lyfjaform með langvarandi verkun
GT199000066A (es) Suspension farmaceutica acuosa para activos farmaceuticos sustancialmente insolubres en agua
BG92179A (bg) Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения
FI843286A (fi) Stabil, sur vattenloesning av cis-platina laemplig foer injektion.
PT93991A (pt) Processo para a preparacao de solucoes estaveis de analogos de rebecamicina
ATE65401T1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
DK443988A (da) Injektionspraeparat indeholdende modificeret tpa
DE3665320D1 (en) Stabilization of peroxidase activity in solution
DK0865422T3 (da) Anvendelse af aminoalkoholderivater som lægemidler, hidtil ukendte derivater og fremgangsmåde til fremstilling deraf
ATE71529T1 (de) Pharmazeutische praeparate zur transdermalen applikation von heparin.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19960902